News
Watch
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Adult Immune Thrombocytopenia Purpura

Adult Immune Thrombocytopenia Purpura

Episodes

Specialty:

All

Year:

All

EP. 1: Adult ITP: Causes and Pathophysiology

January 27th 2020

EP. 2: Risks of Bleeding and Thrombosis in Adult ITP

January 27th 2020

EP. 3: Tests to Aid in the Diagnosis of Adult ITP

January 27th 2020

EP. 4: Adult ITP: When Is It Appropriate to Initiate Therapy?

January 27th 2020

EP. 5: Frontline Corticosteroid Strategies in Adult ITP

January 27th 2020

EP. 6: 2019 ASH Guideline Update on Treating Relapsed/Refractory ITP

January 27th 2020

EP. 7: Targeting Syk in Adult Immune Thrombocytopenic Purpura

January 27th 2020

EP. 8: Syk Inhibition in Adult ITP: The FIT1 and FIT2 Trials

January 27th 2020

EP. 9: Adult Immune Thrombocytopenic Purpura: TPO Receptor Agonists

January 27th 2020

EP. 10: Rituximab or Platelet Transfusion in ITP

January 27th 2020

EP. 11: Later-Line Treatment Options in Adult ITP

January 27th 2020

EP. 12: Adult ITP: Promising Therapeutic Agents in Development

January 27th 2020

EP. 13: Use of Splenectomy in Adult Immune Thrombocytopenic Purpura

January 27th 2020

Trending on OncLive

FDA Approves Zidesamtinib in Pretreated ROS1+ NSCLC

FDA Accepts NDA for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer

Dr Patel on the Unmet Need in EGFR+ Transformed Small Cell Lung Cancer

Dr Galsky on Systemic Therapy Advances in Muscle-Invasive Bladder Cancer

Dr Cooper on Biomarker Selection for DLL3-Targeted Therapies in ES-SCLC